DOI QR코드

DOI QR Code

Analysis of Factors Related to the Use of Korean Medicine Treatment in Patients with Mood Disorders: Based on 2019 Korea Health Panel Annual Data

기분장애 환자에서 한의치료 이용과 관련된 요인분석: 제2기 한국의료패널 자료를 중심으로

  • Kyoungeun Lee (Dong-eui University Korean Medicine Hospital) ;
  • Chan-Young Kwon (Department of Oriental Neuropsychiatry, Dong-eui University College of Korean Medicine)
  • 이경은 (동의대학교부속한방병원) ;
  • 권찬영 (동의대학교 한의과대학 한방신경정신과)
  • Received : 2023.11.01
  • Accepted : 2023.12.16
  • Published : 2023.12.30

Abstract

Objectives: We used the 2019 Korea Health Panel Annual Data to analyze factors related to visits to Korean medicine (KM) outpatient clinics among patients with mood disorders in Korea. Methods: Individuals aged 19 years or older, with depressive or bipolar disorders, and with a record of using Western medicine (WM) and/or the KM medical service were included. The 266 subjects were classified into the WM group or the integrative medicine (IM) group. The Andersen healthcare utilization model was used to analyze factors that potentially influenced the subjects' healthcare utilization. Binomial logistic regression analysis was used to analyze factors influencing the use of IM medical services. Results: Among the subjects, 75.56% (n=201) were in the WM group, and 24.44% (n=65) were in the IM group. Statistically significant differences were observed in residential areas, total annual income, the presence of disability, and the level of pain/discomfort between the two groups. Regression analysis found that residential areas and pain/discomfort were factors related to the use of IM services. Specifically, reporting "a lot" of pain/discomfort compared to "no" pain/discomfort showed a significant positive relationship with the use of IM (odds ratio=4.57, 95% confidence interval=1.79 to 11.70). Conclusions: This study was the first to analyze the status of KM medical service use and related factors among patients with mood disorders in Korea. The finding that the presence of pain/discomfort was positively correlated with the use of KM services is potentially related to medically unexplained physical symptoms or somatization phenomena.

Keywords

Acknowledgement

This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the Grand Information Technology Research Center support program (IITP-2023-2020-0-01791) supervised by the IITP (Institute for Information & communications Technology Planning & evaluation), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI23C1403). This study used the Korea Health Panel Annual Data 2019 (Version 2.0.1) jointly hosted by the Korea Institute for Health and Social Affairs and the National Health Insurance Service.

References

  1. Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry. 2021;55(1):7-117. https://doi.org/10.1177/0004867420979353
  2. Association AP. Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) (5th ed.). Washington: American Psychiatric Association 2013.
  3. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar disorders. 2009;11(5):453-73. https://doi.org/10.1111/j.1399-5618.2009.00726.x
  4. Health Insurance review & assessment service. Healthcare Bigdata hub. Available from:http://opendata. hira.or.kr/op/opc/olapMfrnlntrsllnsInfo.do [Internet].
  5. Gutierrez-Rojas L, Porras-Segovia A, Dunne H, Andrade- Gonzalez N, Cervilla JA. Prevalence and correlates of major depressive disorder: a systematic review. Brazilian Journal of Psychiatry. 2020;42:657-72. https://doi.org/10.1590/1516-4446-2020-0650
  6. Welfare KMoHa. National mental health survey 2021. Sejong2021.
  7. Chow W DM, Sheehan H, Alphs L, Le H. Economic Burden Among Patients With Major Depressive Disorder: An Analysis of Healthcare Resource Use, Work Productivity, and Direct and Indirect Costs by Depression Severity. Am H Manang Care. 2019;. 2019;16:e188-96.
  8. Association AP. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts: American Psychological Association; 2019.
  9. Balsikci A, Uzun O, Erdem M, Doruk A, Cansever A, Ates MA. Side effects that cause noncompliance to antidepressant medications in the course of outpatient treatment. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology. 2014;24(1):69-75. https://doi.org/10.5455/bcp.20120827114140
  10. McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22(3):394-412. https://doi.org/10.1002/wps.21120
  11. Jung Y-E, Kim MD. Psychosocial Treatment for Bipolar Disorder. Mood and Emotion. 2016;14(1):19-24.
  12. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381(9878):1672-82. https://doi.org/10.1016/S0140-6736(13)60857-0
  13. Miklowitz DJ, Johnson SL. Social and familial factors in the course of bipolar disorder: Basic processes and relevant interventions. Clinical Psychology: Science and Practice. 2009;16(2):281.
  14. Qureshi NA, Al-Bedah AM. Mood disorders and complementary and alternative medicine: a literature review. Neuropsychiatric disease and treatment. 2013:639-58.
  15. Seung H-B, Kwon H-J, Kim S-H. Effectiveness and Safety of Traditional East Asian Herbal Medicine as Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis. Journal of Oriental Neuropsychiatry. 2022;33(1):79-111. https://doi.org/10.7231/JON.2022.33.1.079
  16. Lee J-Y, Kim J-Y, Jeong J-H, Jung IC. A Case Study on a Patient with Major Depressive Episode of Bipolar II Disorder Treated with a Combination of Interpersonal and Social Rhythm Therapy and Korean Medicine. Journal of Oriental Neuropsychiatry. 2020;31(3):213-23.
  17. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1-10. https://doi.org/10.2307/2137284
  18. Ryder AG, Yang J, Zhu X, Yao S, Yi J, Heine SJ, et al. The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America? J Abnorm Psychol. 2008;117(2):300-13. https://doi.org/10.1037/0021-843X.117.2.300
  19. Han H, Wang SM, Han C, Lee SJ, Pae CU. The relationship between somatic symptoms and depression. Neuro Endocrinol Lett. 2014;35(6):463-9.
  20. Li Y, Jia S, Cao B, Chen L, Shi Z, Zhang H. Network analysis of somatic symptoms in Chinese patients with depressive disorder. Front Public Health. 2023;11:1079873.
  21. Saint Arnault D, Kim O. Is there an Asian idiom of distress?: Somatic symptoms in female Japanese and Korean students. Archives of psychiatric nursing. 2008;22(1):27-38. https://doi.org/10.1016/j.apnu.2007.10.003
  22. Riem MME, Doedee E, Broekhuizen-Dijksman SC, Beijer E. Attachment and medically unexplained somatic symptoms: The role of mentalization. Psychiatry Res. 2018;268:108-13. https://doi.org/10.1016/j.psychres.2018.06.056
  23. Maes M, Rief W. Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res. 2012;196(2-3):243-9. https://doi.org/10.1016/j.psychres.2011.09.029
  24. Paterson C, Taylor RS, Griffiths P, Britten N, Rugg S, Bridges J, et al. Acupuncture for 'frequent attenders' with medically unexplained symptoms: a randomised controlled trial (CACTUS study). British Journal of General Practice. 2011;61(587):e295-e305. https://doi.org/10.3399/bjgp11X572689
  25. Van Dessel N, Den Boeft M, van der Wouden JC, Kleinstaeuber M, Leone SS, Terluin B, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews. 2014;(11):CD011142.
  26. Johansen M-L, Risor MB. What is the problem with medically unexplained symptoms for GPs? A meta-synthesis of qualitative studies. Patient education and counseling. 2017;100(4):647-54. https://doi.org/10.1016/j.pec.2016.11.015
  27. Lee J, Dong SO, Lee Y, Kim SH, Lee S. Recognition of and interventions for Mibyeong (subhealth) in South Korea: a national web-based survey of Korean medicine practitioners. Integr Med Res. 2014;3(2):60-6. https://doi.org/10.1016/j.imr.2013.09.001
  28. Rugg S, Paterson C, Britten N, Bridges J, Griffiths P. Traditional acupuncture for people with medically unexplained symptoms: a longitudinal qualitative study of patients' experiences. British Journal of General Practice. 2011;61(587):e306-e15. https://doi.org/10.3399/bjgp11X577972
  29. Kim D-S. Study on factors related to the use of oriental medical service among outpatients. Seoul: Graduate School of Public Health Yonsei University; 2013.
  30. Kwon S, Heo S, Kim D, Kang S, Woo JM. Changes in trust and the use of Korean medicine in South Korea: a comparison of surveys in 2011 and 2014. BMC Complement Altern Med. 2017;17(1):463.
  31. Frye MA, Calabrese JR, Reed ML, Hirschfeld RM. Healthcare resource utilization in bipolar depression compared with unipolar depression: results of a United States population-based study. CNS Spectr. 2006;11(9):704-10; quiz 19. https://doi.org/10.1017/S1092852900014796